Eli Lilly Neutralizing Antibodies: Breakthrough for COVID-19 Treatment?

September 16, 2020

Patients afflicted with COVID-19 have an increased susceptibility to antibiotic resistant infections both from prolonged hospitalizations and the use of immunocompromising agents such as dexamethasone.

September 16, 2020

Kevin Kavanagh, MD: “I think you’ll find that infection preventionists in this type of climate are just not healthcare employed personnel. They need to be everywhere. They need to be in business. They need to be in schools. And, of course, they need to be in our healthcare system. But it is crucial to be in schools…”

September 16, 2020

Diversifying roles and creating support staff benefits the team by increasing the productivity of the department and providing a deeper bench so that IPs can focus on broader activities requiring specific subject matter expertise.

September 14, 2020

The effectiveness of UVC for reduction of microorganisms including bacteria, viruses, and fungi has been proven time and again. But using UVC radiation to disinfect is not simple and requires lots of protocols to use safely.

September 11, 2020

Peter Walter, PhD: “We think of AeroNabs as a molecular form of PPE that could serve as an important stopgap until vaccines provide a more permanent solution to COVID-19.”

September 11, 2020

Jonathan Iralu, MD: “We’ve dealt with small outbreaks, not a pandemic, but we were, in a sense, prepped to deal with the pandemic because we have had experience working with outbreaks…. We were used to collaborating with the state and the tribe on these other conditions. For COVID-19, we didn’t have to reinvent the wheel….”

September 10, 2020

The results of the study indicate that a closer working relationship between the antimicrobial stewardship program and the infection control team pays off in lower incidence of C. diff.

September 10, 2020

Join us for the inaugural MJH Life SciencesTM COVID-19 Coalition webinar event, “Battling Dual Threats: Flu and COVID-19 Converge,” featuring perspectives across virology and epidemiology.

September 10, 2020

As these healthcare worker serology studies are designed and performed, we need more insight beyond just PPE use and symptoms, but also internal and external exposures.

September 09, 2020

Jason Tetro: “There are going to be COVID-19 waves every year. What we hope is that that vaccine is going to be able to help us to be able to have that protection whenever those waves are hitting us.”

September 08, 2020

It is imperative that infection preventionists engage and combat this messaging on social media and wherever it occurs. To not do so, allows misinformation to fan the pandemic, placing all of our lives at risk.

September 08, 2020

Infection preventionists need to be able to articulate to those who feel that the young are safe just because their fatality rate is extremely low, that even in this age group there are major concerns regarding long-term consequences of this virus.

September 08, 2020

J. Hudson Garrett Jr., PhD, MSN, MPH: “I think the role of the infection preventionist has always been of the most critical importance. Every time we have an outbreak or, now, a pandemic, it highlights that further.”

September 03, 2020

Melinda Benedict, MS, CIC, CFER: “I think for infection preventions: If you’re not already involved in your endoscopy department or you haven’t been invited in, see if you can get in and just continue to check it out and see what’s going on, especially if the reprocessing and cleaning of the scope is actually done within that clinic.”

September 02, 2020

Anthony Harris, MD, MBA, MPH: “Really now it’s all about testing. How do we test? What scale do we test with? And, you know, what are the steps toward getting that access to the testing levels that we need necessary to mitigate risk?”